Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pre-Market, First-In-Human, Pilot, Interventional, Clinical Investigation to Evaluate Safety and Feasibility of the FieldForce™ Ablation System in Symptomatic Patients With Ventricular Arrhythmia

NCT06203262 is registered in ClinicalTrials.gov with Field Medical as lead sponsor.

NCT NCT06203262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06203262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pre-Market, First-In-Human, Pilot, Interventional, Clinical Investigation to Evaluate Safety and Feasibility of the FieldForce™ Ablation System in Symptomatic Patients With Ventricular Arrhythmia
Lead sponsor
Field Medical
Phase
Not applicable
Overall status
Completed
Start date
April 12, 2024
Completion date
November 28, 2025
Enrollment
34 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pvc - premature ventricular complex, pvc - premature ventricular contraction, ventricular arrythmia, ventricular tachyarrhythmia, ventricular tachycardia